Literature DB >> 24760477

Refractory and super-refractory status epilepticus--an update.

Sara Hocker1, William O Tatum, Suzette LaRoche, W David Freeman.   

Abstract

Status epilepticus is a medical emergency with a high mortality. Early recognition and initiation of treatment leads to a better response and may improve outcomes. Refractory status epilepticus is defined as recurrent seizure activity despite two appropriately selected and dosed antiepileptic drugs including a benzodiazepine. The term "super-refractory status epilepticus" was introduced during the London-Innsbruck Colloquium on status epilepticus in 2011 and refers to status epilepticus that continues or recurs 24 h or more after the initiation of treatment with anesthetic antiepileptic drugs. This includes cases in which seizure control is attained after induction of anesthesia but recurs on weaning the patient off the anesthetic agent. This article reviews the approach to refractory status epilepticus and super-refractory status epilepticus, including management as well as common pathophysiological causes of these entities.

Entities:  

Mesh:

Year:  2014        PMID: 24760477     DOI: 10.1007/s11910-014-0452-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  59 in total

1.  A clinical score for prognosis of status epilepticus in adults.

Authors:  Andrea O Rossetti; Giancarlo Logroscino; Edward B Bromfield
Journal:  Neurology       Date:  2006-06-13       Impact factor: 9.910

2.  Intramuscular versus intravenous therapy for prehospital status epilepticus.

Authors:  Robert Silbergleit; Valerie Durkalski; Daniel Lowenstein; Robin Conwit; Arthur Pancioli; Yuko Palesch; William Barsan
Journal:  N Engl J Med       Date:  2012-02-16       Impact factor: 91.245

Review 3.  Molecular cascades that mediate the influence of inflammation on epilepsy.

Authors:  Alon Friedman; Ray Dingledine
Journal:  Epilepsia       Date:  2011-05       Impact factor: 5.864

Review 4.  Prognostic factors, morbidity and mortality in tonic-clonic status epilepticus: a review.

Authors:  A Neligan; S D Shorvon
Journal:  Epilepsy Res       Date:  2010-10-13       Impact factor: 3.045

5.  Functional and cognitive outcome in prolonged refractory status epilepticus.

Authors:  Alex D Cooper; Jeffrey W Britton; Alejandro A Rabinstein
Journal:  Arch Neurol       Date:  2009-12

6.  Refractory status epilepticus treated with trigeminal nerve stimulation.

Authors:  Brian D Moseley; Christopher M Degiorgio
Journal:  Epilepsy Res       Date:  2013-12-30       Impact factor: 3.045

7.  Refractory status epilepticus: a prospective observational study.

Authors:  Jan Novy; Giancarlo Logroscino; Andrea O Rossetti
Journal:  Epilepsia       Date:  2009-10-08       Impact factor: 5.864

8.  Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study.

Authors:  Nicolas Gaspard; Brandon Foreman; Lilith M Judd; James N Brenton; Barnett R Nathan; Blathnaid M McCoy; Ali Al-Otaibi; Ronan Kilbride; Ivan Sánchez Fernández; Lucy Mendoza; Sophie Samuel; Asma Zakaria; Giridhar P Kalamangalam; Benjamin Legros; Jerzy P Szaflarski; Tobias Loddenkemper; Cecil D Hahn; Howard P Goodkin; Jan Claassen; Lawrence J Hirsch; Suzette M Laroche
Journal:  Epilepsia       Date:  2013-06-12       Impact factor: 5.864

9.  Determinants of mortality in status epilepticus.

Authors:  A R Towne; J M Pellock; D Ko; R J DeLorenzo
Journal:  Epilepsia       Date:  1994 Jan-Feb       Impact factor: 5.864

Review 10.  MicroRNAs in the pathophysiology and treatment of status epilepticus.

Authors:  David C Henshall
Journal:  Front Mol Neurosci       Date:  2013-11-12       Impact factor: 5.639

View more
  10 in total

1.  Phase I/II multicenter ketogenic diet study for adult superrefractory status epilepticus.

Authors:  Mackenzie C Cervenka; Sara Hocker; Matthew Koenig; Barak Bar; Bobbie Henry-Barron; Eric H Kossoff; Adam L Hartman; John C Probasco; David R Benavides; Arun Venkatesan; Eliza C Hagen; Denise Dittrich; Tracy Stern; Batya Radzik; Marie Depew; Filissa M Caserta; Paul Nyquist; Peter W Kaplan; Romergryko G Geocadin
Journal:  Neurology       Date:  2017-02-08       Impact factor: 9.910

Review 2.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

Review 3.  Super-Refractory Status Epilepticus.

Authors:  Mauricio Ruiz Cuero; Panayiotis N Varelas
Journal:  Curr Neurol Neurosci Rep       Date:  2015-11       Impact factor: 5.081

4.  Enhanced AMPA receptor-mediated neurotransmission on CA1 pyramidal neurons during status epilepticus.

Authors:  Suchitra Joshi; Karthik Rajasekaran; Huayu Sun; John Williamson; Jaideep Kapur
Journal:  Neurobiol Dis       Date:  2017-04-02       Impact factor: 5.996

5.  Brexanolone as adjunctive therapy in super-refractory status epilepticus.

Authors:  Eric S Rosenthal; Jan Claassen; Mark S Wainwright; Aatif M Husain; Henrikas Vaitkevicius; Shane Raines; Ethan Hoffmann; Helen Colquhoun; James J Doherty; Stephen J Kanes
Journal:  Ann Neurol       Date:  2017-09-11       Impact factor: 10.422

6.  First-in-man allopregnanolone use in super-refractory status epilepticus.

Authors:  Henrikas Vaitkevicius; Aatif M Husain; Eric S Rosenthal; Jonathan Rosand; Wendell Bobb; Kiran Reddy; Michael A Rogawski; Andrew J Cole
Journal:  Ann Clin Transl Neurol       Date:  2017-04-26       Impact factor: 4.511

7.  Successful Treatment of Super-Refractory Status Epilepticus with High-Intensity Electroconvulsive Therapy - A Case Report and Review of the Current Literature.

Authors:  Hanna Schneegans; Henning Stetefeld; Christian Dohmen; Oezguer A Onur; Fritz-Georg Lehnhardt
Journal:  J Epilepsy Res       Date:  2019-06-30

Review 8.  Super-Refractory Status Epilepticus: Prognosis and Recent Advances in Management.

Authors:  Batool F Kirmani; Katherine Au; Lena Ayari; Marita John; Padmashri Shetty; Robert J Delorenzo
Journal:  Aging Dis       Date:  2021-07-01       Impact factor: 6.745

9.  Indications for Inpatient Magnetoencephalography in Children - An Institution's Experience.

Authors:  Michael W Watkins; Ekta G Shah; Michael E Funke; Stephanie Garcia-Tarodo; Manish N Shah; Nitin Tandon; Fernando Maestu; Christopher Laohathai; David I Sandberg; Jeremy Lankford; Stephen Thompson; John Mosher; Gretchen Von Allmen
Journal:  Front Hum Neurosci       Date:  2021-06-04       Impact factor: 3.169

10.  Therapeutic augmentation of ketogenic diet with a sodium-glucose cotransporter 2 inhibitor in a super-refractory status epilepticus patient.

Authors:  Joseph R Blunck; Joseph W Newman; Ronald K Fields; John E Croom
Journal:  Epilepsy Behav Case Rep       Date:  2018-06-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.